Oliver Lagore Vanvalin Investment Group Neogenomics Inc Transaction History
Oliver Lagore Vanvalin Investment Group
- $359 Million
- Q3 2024
A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Neogenomics Inc stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 400 shares of NEO stock, worth $6,792. This represents 0.0% of its overall portfolio holdings.
Number of Shares
400
Previous 400
-0.0%
Holding current value
$6,792
Previous $5,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NEO
# of Institutions
293Shares Held
124MCall Options Held
698KPut Options Held
120K-
Black Rock Inc. New York, NY19.7MShares$334 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$238 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$117 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$112 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$111 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $2.14B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...